Vestibular migraine: Onabotulinum toxin effectivity, prospective-randomized study
Open Access
- 4 May 2025
- journal article
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 254, 108949
Abstract
No abstract availableKeywords
Funding Information
- Allergan Foundation (IIT-2017-10136)
This publication has 39 references indexed in Scilit:
- Altered structure of the vestibular cortex in patients with vestibular migraineBrain and Behavior, 2020
- Prophylactic treatment of vestibular migraineBrazilian Journal of Otorhinolaryngology, 2016
- Propranolol and venlafaxine for vestibular migraine prophylaxis: A randomized controlled trialThe Laryngoscope, 2015
- Fixed combination of cinnarizine and dimenhydrinate in the prophylactic therapy of vestibular migraine: an observational studyNeurological Sciences, 2015
- Rationale for use of onabotulinum toxin A (BOTOX) in chronic migraineNeurological Sciences, 2015
- Detection of isolated covert saccades with the video head impulse test in peripheral vestibular disordersAuris Nasus Larynx, 2013
- Onabotulinum toxin A for treatment of chronic migraine with medication overuseNeurological Sciences, 2013
- Cervical vestibular evoked myogenic potentials in primary headache disordersClinical Neurophysiology, 2013
- Vestibular-evoked myogenic potentials in vestibular migraineJournal of Neurology, 2009
- A critical review of visual analogue scales in the measurement of clinical phenomenaResearch in Nursing & Health, 1990